Why the study?
Are markers of in vivo platelet activation increased in adolescents with type 2 diabetes compared to those with type 1 diabetes or non-diabetic controls?
Are markers of in vivo platelet activation increased in adolescents with type 2 diabetes compared to those with type 1 diabetes or non-diabetic controls?
Adolescents with type 2 diabetes exhibit increased platelet activation, suggesting an early marker for cardiovascular disease risk.
No takes yet. Share an insight, caveat, or question.
May flag heightened CVD risk in adolescent T2D; leaves open whether it predicts events or warrants intervention.
Israels et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: